During the past decade, UBC/VCHA Eye Care Centre conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UBC/VCHA Eye Care Centre" #1 sponsor was "Jaeb Center for Health Research" with 3 trials, followed by "Clearside Biomedical, Inc." with 1 trials sponsored, "IVERIC bio, Inc." with 1 trials sponsored, "Immunovant Sciences GmbH" with 1 trials sponsored and "University of British Columbia" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UBC/VCHA Eye Care Centre" #1 collaborator was "National Eye Institute (NEI)" with 2 trials as a collaborator, "National Institutes of Health (NIH)" with 2 trials as a collaborator, "Regeneron Pharmaceuticals" with 2 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 1 trials as a collaborator and "Kowa Company, Ltd." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "UBC/VCHA Eye Care Centre" are "Diabetic Macular Edema" (2 trials), "Diabetic Retinopathy" (2 trials), "Geographic Atrophy" (1 trials), "Graves' Ophthalmopathy" (1 trials) and "Macular Degeneration" (1 trials). Many other conditions were trialed in "UBC/VCHA Eye Care Centre" in a lesser frequency.

Most popular intervention types in "UBC/VCHA Eye Care Centre" are "Drug" (6 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "2-mg Intravitreous Aflibercept Injection" (1 trials), "Deferred aflibercept" (1 trials), "Deferred laser" (1 trials), "IVT aflibercept" (1 trials) and "Injection of Avastin / Lucentis, sampling aqueous humour" (1 trials). Other intervention names were less common.

The vast majority of trials in "UBC/VCHA Eye Care Centre" are 7 trials for "All" genders.

Currently, there are NaN active trials in "UBC/VCHA Eye Care Centre". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in UBC/VCHA Eye Care Centre, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in UBC/VCHA Eye Care Centre, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".